发明名称 |
Antibodies against the RGM A protein and uses thereof |
摘要 |
The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind and neutralize RGM A protein. Specifically, these antibodies have the ability to inhibit the binding of RGM A to its receptor and/or coreceptors. These antibodies or portions thereof of the invention are useful for detecting RGM A and for inhibiting RGM A activity, for example in a human suffering from a disorder including but nor limited to multiple sclerosis, mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia. |
申请公布号 |
US8962803(B2) |
申请公布日期 |
2015.02.24 |
申请号 |
US200912389927 |
申请日期 |
2009.02.20 |
申请人 |
AbbVie Deutschland GmbH & Co. KG;AbbVie Inc. |
发明人 |
Mueller Bernhard K.;Schmidt Martin;Barlow Eve;Leddy Mary;Hsieh Chung-Ming;Bardwell Philip |
分类号 |
C07K16/00 |
主分类号 |
C07K16/00 |
代理机构 |
Michael Best & Friedrich LLP |
代理人 |
Mueller Lisa V.;Michael Best & Friedrich LLP |
主权项 |
1. An isolated antibody comprising an antigen binding domain, said antibody capable of binding an epitope of a RGM molecule, said antigen binding domain comprising a heavy chain variable domain having three complementary determining regions
and a light chain variable domain having three complementary determining regions, wherein the three complementary determining regions of the heavy chain variable domain have the amino acid sequence of SEQ ID NO:57, SEQ ID NO:58 and SEQ ID NO:59 and the three complementary determining regions of the light chain variable domain have the amino acid sequence of SEQ ID NO: 60, SEQ ID NO:61 and SEQ ID NO:62. |
地址 |
Wiesbaden DE |